1. Academic Validation
  2. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights

Molecular mechanisms of cardiac pathology in diabetes - Experimental insights

  • Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt B):1949-1959. doi: 10.1016/j.bbadis.2017.10.035.
U Varma 1 P Koutsifeli 2 V L Benson 3 K M Mellor 4 L M D Delbridge 5
Affiliations

Affiliations

  • 1 Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia.
  • 2 Department of Physiology, University of Auckland, New Zealand; Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia.
  • 3 Department of Physiology, University of Auckland, New Zealand.
  • 4 Department of Physiology, University of Auckland, New Zealand; Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia; Auckland Bioengineering Institute, University of Auckland, New Zealand.
  • 5 Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: [email protected].
Abstract

Diabetic cardiomyopathy is a distinct pathology independent of co-morbidities such as coronary artery disease and hypertension. Diminished glucose uptake due to impaired Insulin signaling and decreased expression of glucose transporters is associated with a shift towards increased reliance on fatty acid oxidation and reduced cardiac efficiency in diabetic hearts. The cardiac metabolic profile in diabetes is influenced by disturbances in circulating glucose, Insulin and fatty acids, and alterations in cardiomyocyte signaling. In this review, we focus on recent preclinical advances in understanding the molecular mechanisms of diabetic cardiomyopathy. Genetic manipulation of cardiomyocyte Insulin signaling intermediates has demonstrated that partial cardiac functional rescue can be achieved by upregulation of the Insulin signaling pathway in diabetic hearts. Inconsistent findings have been reported relating to the role of cardiac AMPK and β-adrenergic signaling in diabetes, and systemic administration of agents targeting these pathways appear to elicit some cardiac benefit, but whether these effects are related to direct cardiac actions is uncertain. Overload of cardiomyocyte fuel storage is evident in the diabetic heart, with accumulation of glycogen and lipid droplets. Cardiac metabolic dysregulation in diabetes has been linked with oxidative stress and Autophagy disturbance, which may lead to cell death induction, fibrotic 'backfill' and cardiac dysfunction. This review examines the weight of evidence relating to the molecular mechanisms of diabetic cardiomyopathy, with a particular focus on metabolic and signaling pathways. Areas of uncertainty in the field are highlighted and important knowledge gaps for further investigation are identified. This article is part of a Special issue entitled Cardiac adaptations to obesity, diabetes and Insulin resistance, edited by Professors Jan F.C. Glatz, Jason R.B. Dyck and Christine Des Rosiers.

Keywords

Autophagy; Diabetes; Heart; Metabolism; Oxidative stress.

Figures